Langer, S., L. Mulam, N. Gupta, and J. Kotwal. “Day 21 Serum Free Light Chain (FLC) Levels As a Predictor of Response to Therapy in Symptomatic Multiple Myeloma”. Current Cancer Reports, Vol. 3, no. 1, Sept. 2021, pp. 110-8, doi:10.25082/CCR.2021.01.006.